Uncategorized

Re-Vana Therapeutics Strengthens Executive Team with the Appointments of Michael Nash as Chief Commercial Officer and David Shima, PhD, as Vice President of R&D

by Business Wire • 2021/02/23 • 0 Comments

BELFAST, Northern Ireland--(BUSINESS WIRE)--Re-Vana Therapeutics announced appointments of Michael Nash, Chief Commercial Officer, and David Shima, Vice President of Research and Development.

← Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2021 and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021

Invincible Vision and ReflectionBio Join Forces Ahead of World Rare Disease Day for Bietti’s Crystalline Dystrophy →

Post navigation